ONTARIO BRAIN INSTITUTE - Key Persons
Job Titles:
- Cloud Applications Engineer
Job Titles:
- Advisor, Industry Advisory Council
Job Titles:
- Advisor, Industry Advisory Council / IBM
Job Titles:
- Member of the Board of Directors
- Advisor, Industry Advisory Council / GlaxoSmithKline
Job Titles:
- Member of the Board of Directors
- Advisor, Industry Advisory Council
Job Titles:
- Manager, Informatics & Analytics
Job Titles:
- Program Specialist, Business Development & Partnerships
Job Titles:
- Senior Knowledge Translation Specialist
Job Titles:
- Director, Business Development & Partnerships
Job Titles:
- Advisory, Industry Advisory Council
Job Titles:
- Global Leader
- TELUS Partner Solutions
David Sharma is a global leader with more than two decades of executive and board of director experience.
As the former President of TELUS Enterprise & Partner Solutions, David supported a multi-billion-dollar B2B P&L responsible for the digital transformation of public and private enterprises, SMB, global telecom providers, cloud and content companies.
Prior to this role, David's multi-dimensional experience included Chief Procurement Officer & Global Head of Supply Chain at TELUS responsible for >$6B in annual spend.
David supported passionate team members as the President of TELUS Employer Solutions (TELUS HR BPO business unit) and TELUS Financial Solutions (TELUS Fintech business unit).
As President of TELUS Partner Solutions, David supported global telecom, cloud and content providers.
David was a co-founder of GoCo, which was born through the acquisition of 6 technology companies focused on the SMB marketplace driving SDWAN, Security and UC Solutions.
David received a Bachelor of Mathematics from the University of Waterloo and ACC.DIR designation from the Chartered Governance Institute. David has been recognized with multiple global awards including Global Telecom Business Magazine Top 40 under 40, Women of Influence Diversity Champion and the TELUS Legend award which is TELUS' most prestigious recognition award.
Job Titles:
- Member of the Board of Directors
Dominique Hussey is Vice Chair & Toronto Managing Partner at Bennett Jones. In addition to her management role, she has an active practice, leads the Intellectual Property Litigation group and is co-head of the firm's Innovation, Technology and Branding group. She was named Outstanding Practitioner in Patent Law by Managing IP in their Americas Awards in 2020. For the last four years, Managing Intellectual Property has named her in the Top 250 Women in IP in the world. Dominique's practice involves all aspects of IP litigation and dispute resolution (patent, trademark, copyright, contracts, trade secrets), with particular emphasis on litigation involving pharma/biotech patents, and trademarks. She counsels on trademark, patent, copyright, trade secret, advertising, marketing, packaging, labelling, and regulatory matters-most often pertaining to pharmaceuticals, biologics, legal cannabis, food and beverages, medical devices, and natural health products. Dominique regularly consults on transactions involving IP and regulated industries. She is depended on to structure and negotiate complex strategic settlements and arrangements, with an eye to positive business and litigation outcomes. She also offers her experience to assist clients in navigating the IP aspects of corporate acquisition, re-organization and joint ventures, including, and, with respect to the life sciences and health care industries, the regulatory and competition aspects. Before joining Bennett Jones, Dominique practiced at a large law firm in New York, where she provided litigation and counselling services to pharmaceutical and consumer products companies in the areas of patents, trade secrets and false advertising, with a particular focus on pharmaceutical patent litigation.
Dominique regularly writes, speaks and teaches on the topics of written and oral advocacy, litigation, intellectual property and leadership. Actively involved in several industry organizations, she is a member of the Executive of the 5000-member Advocates' Society. She is also a member of the Board of Directors of the Bennett Jones partnership, on which she served as Lead Director for four years.
Donald T. Stuss, O.C., O. Ont., PhD, FRSC, FCAHS, ABPP-CN, is the Founding President and Scientific Director (2011- 2015) of the Ontario Brain Institute. He is an adjunct (on leave of absence) Senior Scientist at the Rotman Research Institute of Baycrest Centre; University of Toronto Professor of Medicine (Neurology and Rehabilitation Science) and Psychology; founding Director of the Rotman Research Institute, from 1989 to 2008, Reva James Leeds Chair in Neuroscience and Research Leadership 2001-2009, and Vice-President Research, at Baycrest, 1991-2004, 2006-2009; Vice-President Academic Education at Baycrest 2006-2008; interim Director and CEO of the Heart and Stroke Foundation Centre for Stroke Recovery 2008-2009. Honors: Fellow of CPA, APA (Divisions 3, 6, 20, 40), APS, American Heart and Stroke Association, AAAS; University of Toronto Faculty Award (2004); University Professor status, University of Toronto (2004); APA/APF FJ McGuigan Lecture on Understanding the Human Mind (2007); Michener Institute Honorary Diploma (2008); Dr. Gonzalo Rodriquez Lafora Lecture, Spanish Neurological Society (2010); National Academy of Neurosciences 2011 Lifetime Contributions to Neuropsychology Award: 3rd Annual Charles Branch BrainHealth Award, University of Texas at Dallas (2012); Queen Elizabeth II Diamond Jubilee Medal (2012); International Neuropsychological Society Lifetime Achievement Award (2013); Gold Key Award American Congress of Rehabilitation Medicine (2014). His research focuses on understanding and treating the cognitive functions and personality changes associated with the frontal lobes as they occur after stroke, normal elderly, and in those with traumatic brain injury or dementia. He has one co-authored book, and four co-edited books; over 205 publications and 50 chapters; and presented over 270 invited scientific lectures and workshops. His publications have been cited over 18,000 times.
Job Titles:
- McKinsey & Company / Visit Website
Job Titles:
- Global Privacy & Security by Design Centre / Visit Website
Job Titles:
- Advisor, Science Advisory Council / Kessler Foundation
Job Titles:
- Advisor, Evaluation Committee / Lundbeck Foundation
Dr. Diane McIntosh is the founder and CEO of an innovative mental health solution, RAPIDS, and is the Chief Neuroscience Officer at TELUS.
Diane is extensively involved in providing continuing medical education programs to colleagues, nationally and internationally, with a focus on safe, rational prescribing and knowledge translation- sharing the science underlying psychiatric disorders. Whatever her role, her core message remains consistent: we must strive to improve the quality of care and the treatment options available for people diagnosed with a mental illness.
A respected psychiatrist, author, and educator, Dr. Diane McIntosh is a passionate advocate for better mental health care and a tireless champion for Canadians suffering from mental illnesses and their families.
Throughout her career, Diane has worked to raise the profile of mental health issues in Canada and around the world. She has established medical education and advocacy programs, published numerous blogs and op-eds, and lectures widely on mental health issues.
Diane obtained an undergraduate degree in pharmacy before completing her medical school training, two years of a pediatric residency and then an adult psychiatry residency. She is a clinical assistant professor at the University of British Columbia and has a community psychiatry practice.
Diane is the co-founder of SwitchRx, an online medication switching tool for prescribers and pharmacists. She has her own continuing medical education program, PsychedUpCME . Diane's book, This is Depression: A comprehensive and compassionate guide for those who want to understand depression, is written for those who have depression, for those who love someone who is depressed, and for anyone who wants to better understand the disorder. Diane was recognized with the 2020 Canada's Most Powerful Women: Top 100 Award by the Women's Executive Network.
Job Titles:
- Advisor, Evaluation Committee / Saskatchewan Health Quality Council
Job Titles:
- Member of the Board of Directors
- Director, Neuromodulation Research / Medtronic, Inc.
Job Titles:
- Advisor, Science Advisory Council / University of Michigan
Job Titles:
- Member of the Board of Directors
- Advisor, Science Advisory Council / University College London
Job Titles:
- Advisor, Science Advisory Council / Harvard University
Job Titles:
- Board of Directors and Chair, Science Advisory Committee
Job Titles:
- Krembil Centre for Neuroinformatics, Centre for Addiction & Mental Health / Visit Website
Job Titles:
- Advisor, Science Advisory Council / Cambridge University
Job Titles:
- Network Systems Administrator, Operations
Job Titles:
- Advisor, Industry Advisory Council
Job Titles:
- Program Coordinator, Informatics
Job Titles:
- Head, Centre for Analytics
Job Titles:
- Vice President, Business Development & Partnerships
Job Titles:
- Advisor, Industry Advisory Council
Job Titles:
- Vice - Chair
- President and Chief Executive Officer for GE Canada
Heather Chalmers is the President and Chief Executive Officer for GE Canada and leads International Advocacy for GE's suite of technology and products across power, renewables, and digital for GE VERNOVA, GE's portfolio of energy businesses.
Job Titles:
- Program Lead, Informatics Operations
Job Titles:
- Board of Directors and Chair
Job Titles:
- Director, Human Resources
Job Titles:
- Advisor, Industry Advisory Council / Neuraxon Inc.
Job Titles:
- Chief Operating Officer
- Senior Vice President
Job Titles:
- Advisor, Industry Advisory Council
Job Titles:
- Director, Integrated Discovery
Mr. Rotman was Chairman of Roy-L Capital Corporation, a privately-held family investment company. He launched his business career in 1962 after receiving his B.A. from the University of Western Ontario in 1957; M. Comm. from the University of Toronto in 1960; during 1960-61 he studied at the Columbia University Graduate School of Business in the Ph.D. program. In 2012, Mr. Rotman was appointed as Chancellor of Western University for a four-year term. He was awarded honorary degrees from the University of Toronto (1994), Western University (2009), and Memorial University (2013).He was made Officer of the Order of Canada in 1995. Mr. Rotman has been involved in establishing private and public companies and in contributing to advancing Canadian life sciences research; the development of Canada's innovation and commercialization capacity; and related public policy at the federal and provincial levels. He led the creation of the Rotman Research Institute at Baycrest Centre for Geriatric Care affiliated with the University of Toronto, and served two three-year terms on the Governing Council of the Canadian Institutes of Health Research (CIHR), 2000-2006. In 2009, Joseph Rotman was appointed Chair of Grand Challenges Canada, a new global health organization funded by the Federal Government to deliver the Development Innovation Fund announced in the 2008 Budget. Grand Challenges Canada is dedicated to supporting bold ideas with big impact in global health. In 2009, along with Dr. Joseph Martin, Dean Emeritus of Harvard Medical School, Mr. Rotman co-led a major review of the state of brain research in Ontario (2008-09), which led to the recommendation to the Provincial Government that it create the Ontario Brain Institute. In 2013, he was reappointed for a 2nd consecutive five year term as Chair of Canada Council for the Arts. This Crown corporation has for over half a century been the principal conduit of federal support to Canada's professional artists and organizations by grants, endowments and prizes that celebrate creativity by recognizing exceptional Canadians in the arts, humanities and sciences. He has served as a Director on corporate boards including the Bank of Montreal, Barrick Gold Corporation, Canada Northwest Energy Ltd., Masonite International, and TrizecHahn Corp. He served as Chair of the Board as Founder of Tarragon Oil and Gas, Geocrude Energy, and PanCana Resources, amongst others. He is also Founder and Director of Clairvest Group Inc. He was inducted into the Canadian Business Hall of Fame as a Companion in May 2009; presented with the Lifetime Achievement Award from Life Sciences Ontario in February 2012; presented with the Entrepreneur of the Year 2012 Ontario Lifetime Achievement Award from Ernst & Young in October, 2012.
Job Titles:
- Financial Planning and Budget Officer
Job Titles:
- Director, Business Operations / Valeant Pharmaceuticals
Job Titles:
- Program Lead, Knowledge Translation in Integrated Discovery & Informatics
Job Titles:
- Coordinator, Research Administration
Job Titles:
- Vice President, Finance & Operations
Job Titles:
- Advisor, Industry Advisory Council / Pfizer
Job Titles:
- Manager, Investment & Entrepreneurship
Job Titles:
- Board of Directors and Chair, Science Advisory Committee
Job Titles:
- Advisor, Industry Advisory Council / Pfizer
Job Titles:
- Heninger Distinguished Professor
Maryann P. Feldman is the Heninger Distinguished Professor in the Department of Public Policy at the University of North Carolina. Her research and teaching interests focus on the areas of innovation, the commercialization of academic research and the factors that promote technological change and economic growth. Dr. Feldman was the winner of the 2013 Global Award for Entrepreneurship Research, awarded by the Swedish Entrepreneurship Forum and the Research Institute of Industrial Economics, for her contributions to the study of the geography of innovation and the role of entrepreneurial activity in the formation of regional industry clusters. Her dissertation, which was subsequently published as a book, was entitled the Geography of Innovation. The work examined the spatial distribution of industrial innovation and provided an empirical model of the factors and resources that affected the production of new product innovation and was published in the American Economic Review, the Review of Economics and Statistics and the Annuals of the Association of American Geographers. This work is noted to be the first time that the term geography was used to describe spatial phenomenon and is now an accepted lexicon. Currently, the geography of innovation is a subject area under the strategy division of the academy of management.
Maryann Feldman's early work revealed that universities were necessary but not sufficient for technology-based economic development, which launched a new area of investigation into university technology transfer. She has written extensively on the process and mechanics of the commercialization of academic research, publishing in Management Science, Organization Science, Research Policy, and The Journal of Technology Transfer.
Her most recent work is exploring emerging industries, entrepreneurship and the process of regional transformation. This was the topic of the edited book, Cluster Genesis: the origins of technology-based economic development. She has written extensively on the early development and growth of biotechnology, as an example of a transformative technology. She has recently completed a study of the industrial applications of optical science, which will be published in Economic Geography. This work demonstrated typologies of places that were able to sustain industrial optics through a variety of economic development strategies.
While at the Rotman School of Management at the University of Toronto, Maryann worked with Roger Martin, a former director of Monitor Company on a series of papers that examine Jurisdictional Advantage. This work, which examines how places construct unique, not easily replicated economic advantage, has been published in The Brookings Papers on Economic Policy and Research Policy. Maryann Feldman was Principal Investigator on a National Science Foundation Project (SciSIP 0947814) that examined state economic development policies. This work aims to understand what policies are most appropriate in different ecosystems and under different economic conditions.
Currently Maryann is actively engaged in researching the industrial genesis of the Research Triangle region, in a joint project with Nichola Lowe. The project follows the development of the regional economy over a 50-year time period using a unique database of 3200 entrepreneurial ventures and attempts to understand the institutional dynamics that created a vibrant regional economy. This work provides a replicable template for integrating large datasets to use in the study of regional economies.
Job Titles:
- Senior Advisor With the Law Firm Bennett Jones LLP
Michael Horgan is a Senior Advisor with the law firm Bennett Jones LLP. He provides clients with advice on a range of economic, financial sector, energy and environment issues. Mr. Horgan had a 36-year career in the Public Service of Canada where he served as Deputy Minister of four Departments, including the Atlantic Canada Opportunities Agency, Indian and Northern Affairs, and Environment Canada. He retired from the Public Service in April 2014 after five years as Deputy Minister of Finance. He has also held the positions of G7/G20 Finance Deputy for Canada and Executive Director for Canada, Ireland and the Caribbean on the board of the International Monetary Fund. He has also served on a number of Crown corporation boards, including the Bank of Canada, the Canada Mortgage and Housing Corporation, the Canada Deposit Insurance Corporation, and Export Development Canada. Mr. Horgan is currently a Director of the Canadian Ditchley Foundation, the Gairdner Foundation, and the Perimeter Institute for Theoretical Physics.
Mr. Horgan is a recipient of the Prime Minister's Outstanding Achievement Award for Public Service and the Queen's Diamond Jubilee Medal. He has a B.A. in economics from Concordia University (Loyola College) and M.A.'s in economics from Queen's University and Princeton University.
Job Titles:
- Analyst, Business Development & Partnerships
Job Titles:
- President and CEO of Cleveland Clinic Canada
Mike Kessel is the President and CEO of Cleveland Clinic Canada and is responsible for the growth of the Canadian facilities, strategic partnerships and enterprise value creation. During his tenure, the organization has implemented a unique public/private hybrid strategy that has led to formal partnerships with Canadian healthcare ecosystem community stakeholders such as SickKids, Sunnybrook, Mt. Sinai and the Heart and Stroke Foundation. He has also led partnership efforts with the Ontario Ministry of Health, where there have been several important firsts for in-country and cross-border patient care in bariatric surgery and bone marrow transplants. Mr. Kessel led the acquisition of Sports Medicine Specialists - the highest volume sports medicine and rehab clinic in Canada and the first international acquisition in Cleveland Clinic's 100-year history. Over the last few years, Mr. Kessel's focus has been on the creation of a healthcare subscription model (i.e., Netflix) for some of the clinic's services in Canada - medical directorships, virtual care across Canada and remotely focused longitudinal care services. Most importantly, under his leadership, patient experience and employee engagement scores have reached record highs. His career has been fueled by a passion for healthcare and over 25 years of experience in strategy, finance, organizational behavior, operations and entrepreneurial ventures.
In addition to his work at Cleveland Clinic Canada, Mr. Kessel is active in the Toronto community as a former board member of the Heart and Stroke Foundation of Ontario. His involvement was recognized with a Tony Graham Outstanding Board Member Award in 2016. Mr. Kessel created the largest corporate philanthropic table tennis tournament in Canada, which currently takes place in three cities (Vancouver, Toronto, Montreal), and raises $300k annually for the Heart and Stroke Foundation. He also holds board member positions at Unyte, a Toronto-based brain health company; Biomendics, an Ohio-based wound care organization; VIQ, a Toronto-based audio-visual capture company; Solve.care, a health tech company leveraging blockchain to reduce administrative costs; and the Ontario Brain Institute, a non-profit organization that accelerates discovery and innovation, benefiting both patients and the economy. Mr. Kessel is a former committee member of the Conference Board of Canada. He is also an active member of Young Presidents Organization and serves on the Maple Leaf chapter's New Member Committee.
Job Titles:
- As Managing Principal of Navigator, Mike Van Solen Helps Leading Organizations Reach and Engage Their Most Important Audiences
- Managing Principal of Navigator
Mike Van Soelen is the Managing Principal of Navigator where he helps leading organizations reach and engage their most important audiences.
Mike helps lead the Navigator team by providing clients with honest counsel on strategic and crisis communications, public affairs and research. His track record speaks to his unique understanding of how messages properly delivered can facilitate concrete, measurable outcomes.
Before joining Navigator, Mike founded and ran a successful boutique public affairs and communications firm with offices in Toronto and Ottawa that served leading organizations across Canada. Mike sold his firm to Navigator in 2015 and brought his unique insights and results-focused style to the Navigator team.
Prior to running his own company, Mike worked in journalism, communications and government. He began his career in the grassroots of Canadian journalism at two regional daily newspapers, winning several awards for his writing. He moved from journalism to politics, where he served on countless political campaigns. His posts in government have included Chief of Staff to an Ontario Minister and Director of Communications in Ottawa. Mike also worked at one of the country's largest public relations agencies, supporting clients in the finance, health and technology sectors.
Mike appears regularly as a commentator for media outlets such as Global TV, AM 640, CP24 and Newstalk 1010. He also serves as an executive on the board of the Empire Club of Canada.
Job Titles:
- Communications Specialist
Job Titles:
- Senior Lead, Communications
Job Titles:
- Advisor, Outreach Advisory Committee
Job Titles:
- Manager, Research Programs
Job Titles:
- CEO
- President
- Senior Executive
- Member of the Fiscal Federalism Policy Network
Steve Orsini is the President and CEO Council of Ontario Universities.
Steve Orsini has extensive experience in senior executive leadership positions. He is currently the President and CEO of the Council of Ontario Universities (COU). Prior to this role, Steve held several leadership positions in the Ontario Public Service, including Secretary of the Cabinet, Deputy Minister of Finance and Secretary of the Treasury Board, and Deputy Minister of Revenue. Steve also held several leadership positions at the Ontario Hospital Association, including Vice-President of Policy and Public Affairs.
Steve is a member of the Fiscal Federalism Policy Network, a Senior Fellow at the C.D. Howe Institute, a Board Member of the Canadian Ditchley Foundation, and a Distinguished Fellow at the Munk School of Global Affairs and Public Policy, University of Toronto.
Steve holds a Bachelor of Applied Arts in Urban and Regional Planning and a Master's in Environmental Studies.
Susan Fitzpatrick led the James S. McDonnell Foundation when it was one of a limited number of international grant makers supporting university-based research in the biological and behavioural sciences. Susan retired in December 2022 and the McDonnell Foundation subsequently pivoted its focus to improving quality of life in the St. Louis, Missouri region. Susan received her PhD in Biochemistry and Neurology from Cornell University Medical College (1984). After five years pursuing in vivo NMR spectroscopic studies of brain metabolism in the Department of Molecular Biochemistry and Biophysics at Yale University, her career shifted to non-profit administration.
Susan was the Associate Executive Director of the Miami Project to Cure Paralysis (1989-1992), a comprehensive basic science and applied science research center focused on restoring neurological function to persons with spinal cord injury. Her responsibilities included all public outreach and educational efforts, and she served as the scientific liaison to the development, fundraising, and public relations staff. As Executive Director of the Brain Trauma Foundation (1992-1993), she guided the Foundation through a re-organization to become a leader in advancing the acute care of patients with traumatic brain injury. Susan is a visiting professor at the School of Life Sciences, Arizona State University and an adjunct associate professor in the Department of Neuroscience and in the School of Occupational Therapy at Washington University School of Medicine (St. Louis). In addition to her board service with OBI, Susan serves on the governing board of the Marine Biological Laboratory in Woods Hole, MA and One Health Trust India. Susan is a member of the Science Board for the Santa Fe Institute and is an advisory board member with the Institute of Neuroscience and Neurotechnology, Simon Fraser University and with the Koch Center for Family Enterprise at Washington University. Susan lectures and writes on issues concerning the role of private philanthropy in the support of scientific research and on issues related to the public understanding of science.
Sylvie Bove recently retired from her role as Vice President Health and Life Sciences at RISE Research Institutes of Sweden, the national research and innovation institute, where she led the strategy and focused activities within the area. Sylvie has a B.SC in Economics and Business Administration from Upsala University (Sweden), an MBA from Copenhagen Business School/SIMI (Denmark) as well as a Master in Coaching Based Leadership. Prior to that Sylvie pursued studies in biology in France and worked in basic research, among other places at The Basel Institute for Immunology. With such a background it was natural for Sylvie to join the Pharmaceutical industry where she held many commercial positions for over 20 years, among others building the female health/infertility business for Ferring Pharmaceutical, as well as Vice President of Urology/incontinence at Coloplast A/S (Medtech).
In the last 10 years, Sylvie's focus has been accelerating innovation in health, for example building the innovation programme at Lund University Diabetes Center, building a HealthTech cluster in Copenhagen/Denmark as well as EIT Health in Munich where she acted as CEO between 2015 and 2018. For the last 20 years she has held several board positions in biotechs and medtechs, as well as organizations such as Swelife (an organization supporting collaboration within academia, industry, and healthcare, with the goal to strengthen Life Science in Sweden and to improve public health). She is today Chairperson of the board of EIT Health Scandinavia, and Lallianse.com (a private incubator/accelerator in Paris), and sits on the oversight committee of CureHeart, the 30 M GBP project funded by the British Heart Foundation.
Job Titles:
- Chairman of the Board
- Industry Leader
Todd Vienneau is a proven pharmaceutical industry leader with 20 years of experience across multiple disciplines. He is currently Senior Director - Global Medical Affairs at Insulet Canada. Prior to that Todd was National Head, Clinical Specialists & Customer Care -Omnipod and Director, Business Development responsible for New Growth Opportunities at GlaxoSmithKline Canada. He joined GlaxoSmithKline (then GlaxoWellcome) in 1999 and has held multiple senior management positions across many functions including Medical Affairs, Regulatory Affairs and Pharmaceutical Development. In 2006, Todd received GSK's Spirit Award for Leadership. Prior to joining GlaxoSmithKline, Todd was with Proctor & Gamble in both their Canadian and Global operations working in OTC Health Care Product Development and Pharmaceutical New Product Development teams.
During his career Todd has been involved in the development and commercialization of many products across multiple disease areas. His broad functional and therapeutic area experience provides a solid foundation for leading efforts across a wide spectrum of disciplines. Todd holds an Honours Bachelor of Science degree in Biochemistry from the University of Waterloo, has excellent people management and communication skills along with a commercial-oriented strategic focus.
Job Titles:
- President
- Scientific Director
- President and Scientific Director, Institut Ontarien Du Cerveau
Tom Mikkelsen, M.D., FRCPC is the President and Scientific Director of the Ontario Brain Institute (2015-present). He received his MD from the University of Calgary and completed clinical training in neurology at the Montreal Neurological Institute. Following this, he did post-doctoral training in tumour and molecular biology at the Ludwig Institute for Cancer Research in Montreal and then in La Jolla, California. Since 1992, he has led the brain tumour program at Henry Ford Hospital and was responsible for building the clinical trials program and laboratory of tumour biology. Together with other scientists, he helped assemble the Hermelin Brain Tumor Center, a leader in the understanding of the genetics of brain tumours and in the development of treatments for brain tumours. As Co-Director, he participated in the organization's development on many levels spanning from face-to-face clinical care to clinical trials and translational and bench research.
Job Titles:
- Member of the Board of Directors
Job Titles:
- Executive Assistant, President & Executive Office